Terazosin Capsule
Product Images NDC 50090-2371

7 FDA label images from A-s Medication Solutions · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Terazosin (NDC 50090-2371). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by A-s Medication Solutions, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Fig 1)

Structure (Fig 1)
Chemical structure of Terazosin Hydrochloride, showing its molecular composition with rings, amine, ether, and hydrochloride components.*
FDA Label Image

Figure2 (Fig 2)

Figure2 (Fig 2)
The image displays two line graphs comparing the effects of Terazosin versus placebo over a 3-month period. The left graph shows the mean change in total symptom score from baseline with Terazosin decreasing symptoms more than placebo. The right graph illustrates the mean increase in peak flow rate (mL/sec) from baseline, with Terazosin showing a greater improvement than placebo.*
FDA Label Image

Figure3 (Fig 3)

Figure3 (Fig 3)
A line graph depicting mean change from baseline over a 30-month period. The x-axis represents time in months, with data points at intervals from 0 to 30 months. The y-axis indicates mean change values, ranging from 0 to -7. The graph shows a rapid initial decrease followed by a gradual decline, with statistically significant changes marked by asterisks at various points along the timeline.*
FDA Label Image

Figure4 (Fig 4)

Figure4 (Fig 4)
A line graph showing mean change from baseline (in mL/sec) over a 30-month period. The x-axis represents months from 0 to 30, and the y-axis shows changes from 0.0 to 4.5. Data points include error bars and asterisks indicating statistical significance at various time points.*
FDA Label Image

Label Image (Lbl500901559)

Label Image (Lbl500901559)
Terazosin 5 mg oral capsules packaging label from A-S Medication Solutions. The label shows product number 4875-0, a lot number placeholder, storage instructions to store between 68 to 77 degrees Fahrenheit protecting from light and moisture, and a quantity of 30 capsules. The active ingredient is terazosin hydrochloride equivalent to terazosin 5 mg.*
FDA Label Image

Label Image (Lbl500902371)

Label Image (Lbl500902371)
Terazosin 10 mg capsules packaging label from A-S Medication Solutions. The label indicates a product lot number, storage instructions to keep between 68 to 77 degrees Fahrenheit protected from light and moisture, and a count of 90 capsules. It includes labeler and location details with directions to use as prescribed by a doctor.*
FDA Label Image

Label Image (Lbl500902623)

Label Image (Lbl500902623)
Terazosin 2 mg oral capsules label from A-S Medication Solutions. The label includes storage instructions to keep at 68 to 77 degrees Fahrenheit, protecting from light and moisture. It contains 30 capsules per package and provides a QR code for dosage and package insert information. Labeler location is Libertyville, IL 60048.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.